Page last updated: 2024-10-26

fendiline and Anemia, Sickle Cell

fendiline has been researched along with Anemia, Sickle Cell in 1 studies

Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellory, JC1
Nash, GB1
Stone, PC1
Culliford, SJ1
Horwitz, E1
Stuart, J1

Other Studies

1 other study available for fendiline and Anemia, Sickle Cell

ArticleYear
Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
    British journal of pharmacology, 1992, Volume: 106, Issue:4

    Topics: Anemia, Sickle Cell; Azepines; Bepridil; Calcium; Calcium Channel Blockers; Erythrocytes, Abnormal;

1992